These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5702183)

  • 1. [Changes in the magnesium content of hair, urine and blood plasma following oral magnesium administration in humans and the importance of these findings regarding the therapy of oxalate urolithiasis].
    Schneider HJ; Anke M
    Z Urol Nephrol; 1968 Jun; 61(6):361-5. PubMed ID: 5702183
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M; Ikegami M; Kiwamoto H; Umekawa T; Ishikawa Y; Kohri K; Kurita T
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The urinary excretion of oxalic acid and magnesium in oxalate urolithiasis.
    Takasaki E; Shimano E
    Invest Urol; 1967 Nov; 5(3):303-12. PubMed ID: 6073639
    [No Abstract]   [Full Text] [Related]  

  • 4. The urinary calcium-magnesium ratio in calcigerous stone formers.
    King JS; O'Connor FJ; Smith MJ; Crouse L
    Invest Urol; 1968 Jul; 6(1):60-5. PubMed ID: 5663560
    [No Abstract]   [Full Text] [Related]  

  • 5. [Drinking cure with sea water. A contribution on magnesium therapy].
    Schneider HJ; Horn G
    Z Urol Nephrol; 1968 Nov; 61(11):753-60. PubMed ID: 5730225
    [No Abstract]   [Full Text] [Related]  

  • 6. [The excretion of oxalates in urine following oral administration of oxalic acid and magnesium].
    Berg W; Schneider HJ; Vogel E
    Dtsch Z Verdau Stoffwechselkr; 1975; 35(5):241-5. PubMed ID: 1225513
    [No Abstract]   [Full Text] [Related]  

  • 7. A cautious use of sodium cellulose phosphate in the management of calcium nephrolithiasis.
    Pak CY
    Invest Urol; 1981 Nov; 19(3):187-90. PubMed ID: 7298289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnesium metabolism in renal stone disease.
    Johansson G; Backman U; Danielson BG; Ljunghall S; Wikström B
    Invest Urol; 1980 Sep; 18(2):93-6. PubMed ID: 7410037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The mineral content of the hair of the head of kidney calculi patients and its relations to the sort of the calculi].
    Schneider HJ
    Z Gesamte Inn Med; 1969 Feb; 24(3):85-91. PubMed ID: 5796645
    [No Abstract]   [Full Text] [Related]  

  • 10. Reduction of urine oxalate during long-term thiazide therapy in patients with calcium urolithiasis.
    Cohanim M; Yendt ER
    Invest Urol; 1980 Sep; 18(2):170-3. PubMed ID: 7410033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renacidin irrigation of the ileal conduit: a study of systemic magnesium absorption.
    Schellhammer PF; Koontz WW
    Invest Urol; 1974 Sep; 12(2):92-7. PubMed ID: 4854101
    [No Abstract]   [Full Text] [Related]  

  • 12. [Various physical and chemical examinations on the formation and solubility of kidney calculi (with reference to calcium and magnesium containing concrements oxalate-phosphate)].
    Kallistratos G
    Z Urol Nephrol; 1972 Aug; 65(8):607-18. PubMed ID: 4650100
    [No Abstract]   [Full Text] [Related]  

  • 13. Magnesium metabolism in renal stone formers. Effects of therapy with magnesium hydroxide.
    Johansson G; Backman U; Danielson BG; Fellström B; Ljunghall S; Wikström B
    Scand J Urol Nephrol Suppl; 1980; 53():125-34. PubMed ID: 6937988
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of calcium, aluminium, magnesium and cholestyramine on hyperoxaluria in patients with jejunoileal bypass.
    Nordenvall B; Backman L; Larsson L; Tiselius HG
    Acta Chir Scand; 1983; 149(1):93-8. PubMed ID: 6837229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibition of calcium oxalate urolithiasis with pyridoxine and magnesium in an experiment].
    Krídl J; Zvara V; Revúsová V; Gratzlová J; Ondrus B
    Bratisl Lek Listy; 1984 Jan; 81(1):21-8. PubMed ID: 6692164
    [No Abstract]   [Full Text] [Related]  

  • 16. Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate.
    Hesse A; Schneeberger W; Engfeld S; Von Unruh GE; Sauerbruch T
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S329-33. PubMed ID: 10541257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical and animal experiment studies on the pathogenetic significance of small intestine diseases and resections for urolithiasis].
    Schäfer F; Gutsche B
    Z Urol Nephrol; 1983 Jul; 76(7):433-7. PubMed ID: 6637170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of a magnesium-enriched diet on electrolyte metabolism and oxalate excretion in kidney diseases in children].
    Gurvich DB; Korovina NA
    Vopr Pitan; 1981; (4):27-30. PubMed ID: 7293102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of dietary calcium and oxalate ratio on urinary stone formation in rats.
    Morozumi M; Ogawa Y
    Mol Urol; 2000; 4(4):313-20. PubMed ID: 11156697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorptive hyperoxaluria leads to an increased risk for urolithiasis or nephrocalcinosis in cystic fibrosis.
    Hoppe B; von Unruh GE; Blank G; Rietschel E; Sidhu H; Laube N; Hesse A
    Am J Kidney Dis; 2005 Sep; 46(3):440-5. PubMed ID: 16129205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.